241 related articles for article (PubMed ID: 29107382)
1. Human monoclonal antibodies neutralizing influenza virus A/H1N1pdm09 and seasonal A/H1N1 strains - Distinct Ig gene repertoires with a similar action mechanism.
Hiroi S; Kuhara M; Kishi Y; Ono KI; Matsuzawa S; Yamamoto N; Komano J
Immunobiology; 2018 Mar; 223(3):319-326. PubMed ID: 29107382
[TBL] [Abstract][Full Text] [Related]
2. A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin.
Sautto GA; Kirchenbaum GA; Abreu RB; Ecker JW; Pierce SR; Kleanthous H; Ross TM
J Immunol; 2020 Jan; 204(2):375-385. PubMed ID: 31811019
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
[TBL] [Abstract][Full Text] [Related]
4. An epitope on the stem region of hemagglutinin of H1N1 influenza A virus recognized by neutralizing monoclonal antibody.
Yan L; Wang H; Sun L; Liu Y; Sun J; Zhao X; Li Y; Xie X; Hu J
Biochem Biophys Res Commun; 2019 Oct; 518(2):319-324. PubMed ID: 31421820
[TBL] [Abstract][Full Text] [Related]
5. A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses.
Boonsathorn N; Panthong S; Koksunan S; Chittaganpitch M; Phuygun S; Waicharoen S; Prachasupap A; Sasaki T; Kubota-Koketsu R; Yasugi M; Ono K; Arai Y; Kurosu T; Sawanpanyalert P; Ikuta K; Watanabe Y
Biochem Biophys Res Commun; 2014 Sep; 452(3):865-70. PubMed ID: 25204499
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus.
Lin X; Yang F; Yan S; Wu H; Wang P; Zhao Y; Shi D; Yao H; Wu H; Li L
Virus Res; 2024 Jul; 345():199402. PubMed ID: 38772446
[TBL] [Abstract][Full Text] [Related]
7. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
[TBL] [Abstract][Full Text] [Related]
8. Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model.
Zhu P; Yi X; Zhang L; Liu Y; Wang S; Gu J; Zhu X; Yu X
Cell Immunol; 2021 Jan; 359():104255. PubMed ID: 33316647
[TBL] [Abstract][Full Text] [Related]
9. Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.
Klausberger M; Tscheliessnig R; Neff S; Nachbagauer R; Wohlbold TJ; Wilde M; Palmberger D; Krammer F; Jungbauer A; Grabherr R
PLoS One; 2016; 11(4):e0153579. PubMed ID: 27088239
[TBL] [Abstract][Full Text] [Related]
10. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
[TBL] [Abstract][Full Text] [Related]
11. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of new monoclonal antibodies against swine origin 2009 influenza A (H1N1) virus and evaluation of their prophylactic and therapeutic efficacy in a mouse model.
Wang SF; Tseng SP; Loh EW; Wang WH; Li MC; Chen KH; Tsai WC; Lee YM; Chen HY; Liu FT; Arthur Chen YM; Huang JC
Dev Comp Immunol; 2017 Feb; 67():8-17. PubMed ID: 27984103
[TBL] [Abstract][Full Text] [Related]
13. Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach.
Sun W; Kirkpatrick E; Ermler M; Nachbagauer R; Broecker F; Krammer F; Palese P
J Virol; 2019 Jun; 93(12):. PubMed ID: 30944178
[TBL] [Abstract][Full Text] [Related]
14. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B.
Gong X; Yin H; Shi Y; He X; Yu Y; Guan S; Kuai Z; Haji NM; Haji NM; Kong W; Shan Y
Emerg Microbes Infect; 2016 May; 5(5):e51. PubMed ID: 27222326
[TBL] [Abstract][Full Text] [Related]
16. Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the Hemagglutinin Head Domain.
Gao R; Sreenivasan CC; Sheng Z; Hause BM; Zhou B; Wentworth DE; Clement T; Rausch D; Brunick C; Christopher-Hennings J; Wu H; Bausch CL; Sullivan EJ; Hoppe AD; Huber VC; Wang D; Li F
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847862
[TBL] [Abstract][Full Text] [Related]
17. Conserved stem fragment from H3 influenza hemagglutinin elicits cross-clade neutralizing antibodies through stalk-targeted blocking of conformational change during membrane fusion.
Gong X; Yin H; Shi Y; Guan S; He X; Yang L; Yu Y; Kuai Z; Jiang C; Kong W; Wang S; Shan Y
Immunol Lett; 2016 Apr; 172():11-20. PubMed ID: 26875772
[TBL] [Abstract][Full Text] [Related]
18. Oligomerization of bacterially expressed H1N1 recombinant hemagglutinin contributes to protection against viral challenge.
Kuenstling TE; Sambol AR; Hinrichs SH; Larson MA
Sci Rep; 2018 Aug; 8(1):11856. PubMed ID: 30087372
[TBL] [Abstract][Full Text] [Related]
19. Development of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009) using plasmid DNA immunogen.
Cabral TM; Baig A; Berhane Y; Schmidt L; Hole K; Leith M; Kobasa D; Corbett CR
J Virol Methods; 2014 Jan; 195():54-62. PubMed ID: 24060631
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant.
Cheong Y; Kim M; Ahn J; Oh H; Lim J; Chae W; Yang SW; Kim MS; Yu JE; Byun S; Jang YH; Seong BL
Front Immunol; 2021; 12():769088. PubMed ID: 34868027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
